Wechselwirkungen von Atracurium

Use of atracurium besylate from multiple dose vials containing benzyl alcohol as a preservative is contraindicated in patients with a known hypersensitivity to benzyl alcohol. (Fachinformation zu Atracurium, Gegenanzeigen)

Avoid concomitant use with neuromuscular blocking agents. (Fachinformation zu Chinin, Warnhinweise und Vorsichtsmaßnahmen)

The possibility of the occurrence of neuromuscular blockage and respiratory paralysis should be considered if neomycin is administered, especially to patients receiving anesthetics, neuromuscular blocking agents such as tubocurarine, succinylcholine, decamethonium, or in patients receiving massive transfusions of citrate anticoagulated blood. (Fachinformation zu Neomycin, Boxed Warning (umrahmter Warnhinweis))

During therapy with ZEMDRI, monitor for adverse reactions associated with neuromuscular blockade, particularly in high-risk patients, such as patients with underlying neuromuscular disorders (including myasthenia gravis) or in patients concomitantly receiving neuromuscular blocking agents [see Warning and Precautions (5.3) ] . (Fachinformation zu Plazomicin, Boxed Warning (umrahmter Warnhinweis))

In the case of life-threatening muscle rigidity, a rapid onset neuromuscular blocker or naloxone may be administered. (Fachinformation zu Remifentanil, Warnhinweise und Vorsichtsmaßnahmen)

Rocuronium Bromide Injection is contraindicated in patients known to have hypersensitivity (e.g., anaphylaxis) to rocuronium bromide or other neuromuscular blocking agents [see Warnings and Precautions ( 5.2 )] . (Fachinformation zu Rocuronium, Gegenanzeigen)

Reversal of Neuromuscular Blocking Agents Other Than Rocuronium or Vecuronium Do not use BRIDION to reverse blockade induced by nonsteroidal neuromuscular blocking agents such as succinylcholine or benzylisoquinolinium compounds. (Fachinformation zu Sugammadex, Warnhinweise und Vorsichtsmaßnahmen)

Atracurium should not be administered until a patient has recovered from succinylcholine-induced neuromuscular block. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (Fachinformation zu Atracurium, Warnhinweise)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (Fachinformation zu Atracurium, Warnhinweise)

• Neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. (Fachinformation zu Clindamycin, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Myopathy Patients receiving corticosteroids, including EMFLAZA, and concomitant therapy with neuromuscular blocking agents (e.g., pancuronium) or patients with disorders of neuromuscular transmission (e.g., myasthenia gravis) may be at increased risk of developing acute myopathy. (Fachinformation zu Deflazacort, Warnhinweise und Vorsichtsmaßnahmen)

Neuromuscular Blocking Agents Anesthetic concentrations of desflurane at equilibrium (administered for 15 or more minutes before testing) reduced the ED 95 of succinylcholine by approximately 30% and that of atracurium and pancuronium by approximately 50% compared to N 2 O/opioid anesthesia (see Table 4). (Fachinformation zu Desfluran, Arzneimittelwechselwirkungen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

• Risks of Skeletal Muscle Rigidity and Skeletal Muscle Movement : Manage with neuromuscular blocking agent. (Fachinformation zu Fentanyl, Warnhinweise und Vorsichtsmaßnahmen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (Fachinformation zu Atracurium, Warnhinweise)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Drug Interactions Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents; therefore, it should be used with caution in patients receiving such agents. (Fachinformation zu Lincomycin, Arzneimittelwechselwirkungen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (Fachinformation zu Atracurium, Warnhinweise)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Piperacillin and Tazobactam for Injection and Sodium Chloride Injection may prolong the neuromuscular blockade of vecuronium and other non-depolarizing neuromuscular blockers. (Fachinformation zu Piperacillin und Tazobactam, Arzneimittelwechselwirkungen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Depolarizing neuromuscular blocking agents: Increased effect. (Fachinformation zu Pyridostigmin, Arzneimittelwechselwirkungen)

When used to supplement alfentanil-N 2 O anesthesia, sevoflurane and isoflurane equally potentiate neuromuscular block induced with pancuronium, vecuronium or atracurium. (Fachinformation zu Sevofluran, Arzneimittelwechselwirkungen)

If other muscle relaxants are used during the same procedure, the possibility of a synergistic or antagonist effect should be considered. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Drug Interactions Drugs which may enhance the neuromuscular blocking action of atracurium include: enflurane; isoflurane; halothane; certain antibiotics, especially the aminoglycosides and polymyxins; lithium; magnesium salts; procainamide; and quinidine. (Fachinformation zu Atracurium, Arzneimittelwechselwirkungen)

Precautions should also be taken in those individuals who have had previous anaphylactic reactions to other neuromuscular blocking agents since cross-reactivity between neuromuscular blocking agents, both depolarizing and non-depolarizing, has been reported in this class of drugs. (Fachinformation zu Atracurium, Warnhinweise)

Neuromuscular Blocking Agents Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). (Fachinformation zu Verapamil, Arzneimittelwechselwirkungen)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

N e uromuscular Blocking Agents Resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents pancuronium, vecuronium, rocuronium and cisatracurium has occurred in patients chronically administered carbamazepine. (Fachinformation zu Carbamazepin, Arzneimittelwechselwirkungen)

Norepinephrine Dopamine Neuromuscular Blocking Agents Succinylcholine May cause sudden extrusion of potassium from muscle cells causing arrhythmias in patients taking digoxin. (Fachinformation zu Digoxin, Arzneimittelwechselwirkungen)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (Fachinformation zu Atracurium, Warnhinweise)

In patients who have received neuromuscular blocking agents, doxapram may temporarily mask the residual effects of these drugs. (Fachinformation zu Doxapram, Arzneimittelwechselwirkungen)

Neuromuscular blocking agents Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. (Fachinformation zu Fosphenytoin, Arzneimittelwechselwirkungen)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (Fachinformation zu Atracurium, Warnhinweise)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

Neuromuscular blocking agents Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. (Fachinformation zu Phenytoin, Arzneimittelwechselwirkungen)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (Fachinformation zu Atracurium, Warnhinweise)

Atracurium besylate injection, which has an acid pH, should not be mixed with alkaline solutions (e.g., barbiturate solutions) in the same syringe or administered simultaneously during intravenous infusion through the same needle. (Fachinformation zu Atracurium, Warnhinweise)

Common Neuromuscular Blocking Agents DIPRIVAN does not cause a clinically significant change in onset, intensity or duration of action of the commonly used neuromuscular blocking agents (e.g., succinylcholine and nondepolarizing muscle relaxants). (Fachinformation zu Propofol, Arzneimittelwechselwirkungen)

ANTICHOLINESTERASE REVERSAL AGENTS SHOULD BE IMMEDIATELY AVAILABLE. (Fachinformation zu Atracurium, Warnhinweise)

Neuromuscular Blockers In one study of 10 healthy adult volunteers, administration of PRECEDEX for 45 minutes at a plasma concentration of one ng/mL resulted in no clinically meaningful increases in the magnitude of neuromuscular blockade associated with rocuronium administration. (Fachinformation zu Dexmedetomidin, Arzneimittelwechselwirkungen)

Alfentanil and Atracurium Ondansetron does not alter the respiratory depressant effects produced by alfentanil or the degree of neuromuscular blockade produced by atracurium. (Fachinformation zu Ondansetron, Arzneimittelwechselwirkungen)